MedTrace Logo

Cancer Development In Organ Transplant Recipients

NCT02333279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2019-07-29

No results posted yet for this study

Summary

The investigators will determine the cancer risk in organ transplant recipients compared to the general population with the help of statistical analysis. Secondly the investigators will try to characterize the different cancer types.

Conditions

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • Cantonal Hospital of St. Gallen

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • University of Lausanne Hospitals

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Gunther FL Hofbauer, MD · University Hospital, Zürich

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2018-05-31
Completion
2019-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02333279 on ClinicalTrials.gov